Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 72 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning.
Antón MJ, Molina M, Pérez JG, Pina S, Tapiador N, De La Calle B, Martínez M, Ortega P, Ruspaggiari MB, Tudela C, Conejo M, Leno P, López M, Marhuenda C, Arias-Cabrales C, Maisonobe P, Herrera A, Candau E
Toxins (Basel), 16(8):340, 02 Aug 2024
Cited by: 0 articles | PMID: 39195750 | PMCID: PMC11359065
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Assessment of pain relief after four botulinum toxin A injection cycles in patients with post-stroke lower limb spasticity: A prospective, observational study.
Vázquez Doce A, De León García FJ, Mena A, Ortiz-Fernández L, Spottorno MP, Medina F, Maisonobe P, Herrera A, García I, Juan-García FJ, RELIEF investigators group
Rehabilitacion (Madr), 58(3):100856, 24 May 2024
Cited by: 1 article | PMID: 38795502
Add to export list
Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries.
Rosales RL, Chia NVC, Kumthornthip W, Goh KJ, Mak CS, Kong KH, Ng YS, Chou LW, Flordelis MJ, Do T, Maisonobe P, Li LSW, Suputtitada A
Front Neurol, 15:1335365, 08 Apr 2024
Cited by: 1 article | PMID: 38651107 | PMCID: PMC11034516
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity.
Bezzina C, Degtiar V, Danchenko N, Maisonobe P, Davis B, Engmann E, Guyon E, Lecanuet S, Whalen J
Toxins (Basel), 15(9):532, 30 Aug 2023
Cited by: 0 articles | PMID: 37755958 | PMCID: PMC10534376
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study.
Esquenazi A, Zorowitz RD, Ashford S, Maisonobe P, Page S, Jacinto J
J Rehabil Med, 55:jrm4257, 05 Oct 2023
Cited by: 1 article | PMID: 37794845 | PMCID: PMC10562995
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults.
Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Lianza S, Rocha ECM, Maisonobe P, Cuperman-Pohl T, Khan P
Toxins (Basel), 14(11):809, 20 Nov 2022
Cited by: 0 articles | PMID: 36422983 | PMCID: PMC9692702
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation.
Turner-Stokes L, Fheodoroff K, Jacinto J, Lambert J, De La Loge C, Calvi-Gries F, Whalen J, Lysandropoulos A, Maisonobe P, Ashford S
J Rehabil Med, 54:jrm00243, 03 Jan 2022
Cited by: 1 article | PMID: 34726764 | PMCID: PMC8862650
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.
Lew MF, Hauser RA, Isaacson SH, Truong D, Patel AT, Brashear A, Ondo W, Maisonobe P, Dashtipour K, Bahroo L, Wietek S
Clin Park Relat Disord, 5:100115, 20 Nov 2021
Cited by: 0 articles | PMID: 34888518 | PMCID: PMC8636802
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol.
Esquenazi A, Ayyoub Z, Verduzco-Gutierrez M, Maisonobe P, Otto J, Patel AT
Adv Ther, 38(11):5623-5633, 25 Sep 2021
Cited by: 4 articles | PMID: 34562231 | PMCID: PMC8475311
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness.
Turner-Stokes L, Fheodoroff K, Jacinto J, Lambert J, De La Loge C, Calvi-Gries F, Whalen J, Lysandropoulos A, Maisonobe P, Ashford S
J Rehabil Med, 54:jrm00244, 03 Jan 2022
Cited by: 2 articles | PMID: 34726763 | PMCID: PMC8862643
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.
Gracies JM, Francisco GE, Jech R, Khatkova S, Rios CD, Maisonobe P, ENGAGE Study Group
J Neurol Phys Ther, 45(3):203-213, 01 Jul 2021
Cited by: 4 articles | PMID: 34039905 | PMCID: PMC8191476
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Treatment satisfaction in patients with cervical dystonia : Subgroup analysis of INTEREST-IN-CD-2].
Ip CW, Schramm A, Maisonobe P, Zaragatski E, Sycha T
Nervenarzt, 92(12):1268-1275, 03 May 2021
Cited by: 0 articles | PMID: 33942135 | PMCID: PMC8648643
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Corrigendum to AbobotulinumtoxinA injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.
Lejeune T, Khatkova S, Turner-Stokes L, Picaut P, Maisonobe P, Balcaitiene J, Boyer FC
J Rehabil Med, 53(5):jrm00187, 03 May 2021
Cited by: 0 articles | PMID: 33937918 | PMCID: PMC8814836
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group
J Rehabil Med, 53(2):jrm00157, 24 Feb 2021
Cited by: 15 articles | PMID: 33616192 | PMCID: PMC8814868
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC
Toxins (Basel), 12(12):E770, 04 Dec 2020
Cited by: 4 articles | PMID: 33291807 | PMCID: PMC7762077
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR
Zh Nevrol Psikhiatr Im S S Korsakova, 121(11):39-48, 01 Jan 2021
Cited by: 1 article | PMID: 34932284
Add to export list
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
Patel AT, Lew MF, Dashtipour K, Isaacson S, Hauser RA, Ondo W, Maisonobe P, Wietek S, Rubin B, Brashear A
PLoS One, 16(4):e0250475, 14 Apr 2021
Cited by: 0 articles | PMID: 33852647 | PMCID: PMC8046252
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study.
Smit R, Gubanova E, Kaufman J, Landau M, Molina B, Andriopoulos B, Maisonobe P, Prygova I, Redaelli A
J Clin Aesthet Dermatol, 14(2):E69-E88, 01 Feb 2021
Cited by: 2 articles | PMID: 34221231 | PMCID: PMC8211347
Add to export list Review Free full text in Europe PMC
AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles.
Dashtipour K, Wietek S, Rubin B, Maisonobe P, Bahroo L, Trosch R
J Clin Mov Disord, 7:8, 31 Aug 2020
Cited by: 1 article | PMID: 32884828 | PMCID: PMC7457764
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity-III (ULIS-III) study group
J Rehabil Med, 53(1):jrm00133, 01 Jan 2021
Cited by: 7 articles | PMID: 33206198 | PMCID: PMC8772374
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
Patel AT, Lew MF, Dashtipour K, Isaacson S, Hauser RA, Ondo W, Maisonobe P, Wietek S, Rubin B, Brashear A
PLoS One, 16(2):e0245827, 01 Feb 2021
Cited by: 4 articles | PMID: 33524060 | PMCID: PMC7850472
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
Colosimo C, Charles D, Misra VP, Maisonobe P, Om S, INTEREST IN CD2 study group
J Neurol Sci, 416:117015, 09 Jul 2020
Cited by: 6 articles | PMID: 32682125
Add to export list
Composite active range of motion (CX_A) and relationship with active function in upper and lower limb spastic paresis.
Bayle N, Maisonobe P, Raymond R, Balcaitiene J, Gracies JM
Clin Rehabil, 34(6):803-811, 26 Apr 2020
Cited by: 4 articles | PMID: 32336148 | PMCID: PMC7263039
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Abobotulinumtoxina injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.
Lejeune T, Khatkova S, Turner-Stokes L, Picaut P, Maisonobe P, Balcaitiene J, Boyer FC
J Rehabil Med, 52(6):jrm00068, 11 Jun 2020
Cited by: 3 articles | PMID: 32451555
Add to export list
Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.
Misra VP, Danchenko N, Maisonobe P, Lundkvist J, Hunger M
J Clin Mov Disord, 7:6, 29 Jul 2020
Cited by: 0 articles | PMID: 32742709 | PMCID: PMC7390106
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 72 results

1 2 3

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning.

Assessment of pain relief after four botulinum toxin A injection cycles in patients with post-stroke lower limb spasticity: A prospective, observational study.

Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries.

A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity.

Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study.

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults.

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation.

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.

AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol.

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness.

Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.

[Treatment satisfaction in patients with cervical dystonia : Subgroup analysis of INTEREST-IN-CD-2].

Corrigendum to AbobotulinumtoxinA injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.

Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.

The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.

Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study.

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles.

Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.

Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.

Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.

Composite active range of motion (CX_A) and relationship with active function in upper and lower limb spastic paresis.

Abobotulinumtoxina injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.

Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.

Partnerships & funding